Company Email Format Management

Immunovia AB

Biotechnology Research Se 23 employees SYMBO

Employees: 23
Contacts: 2
Emails: 2

immunovia.com LinkedIn Crunchbase

Immunovia AB Overview

Headquarters: Se
Phone Number: Available in AeroLeads
Website: immunovia.com
Industry: Biotechnology Research
Employees: 23
Founded: 2007
Stock Symbol: SYMBO
Funding: 4.5M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Pancreatic cancer Early diagnosis of cancer Cancer therapy monitoring Patient classification Blood-based tests Antibody microarray technology Serum biomarker signatures and Autoimmune diseases diagnosis prognosis and therapy monitoring

About Immunovia AB

Immunovia AB (publ.) is a lean, focused diagnostic company seeking to revolutionize early detection of pancreatic cancer. We aim to improve outcomes for people at high risk of pancreatic cancer by detecting the disease at Stage 1 or 2 with our highly accurate blood test, PancreaSure. Immunovia plans to launch PancreaSure in the United States in the second half of 2025. Immunovia was founded in Lund, Sweden based on protein research at Lund University. The company’s clinical lab and many of its employees are in the U.S.A., the company’s first commercial market. Immunovia stock trades on the Nasdaq Stockholm exchange under the ticker symbol IMMNOV. Visit our website for more information.

Immunovia AB Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage

Immunovia AB Org Chart

Sample employees and titles

Name	Title	Location	Contact
Melissa Farina		Greater Boston, United States	View
Naphtali Milliken	Medical Laboratory Science		View
Jeff Borcherding	Chief Executive Officer at Immunovia	Cincinnati, Ohio, United States	Email
Martin Moller	Board Member, Advisor, Senior Partner	Copenhagen, Capital Region of Denmark, Denmark	Email